Endothel Pharma ApS: Financial statements 2018
CVR: 37988936
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Endothel Pharma ApS (CVR 37988936) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -52,984 and a net result of DKK -59,310. Equity in the 2018 report amounted to DKK -40,424.
- Gross Profit
- DKK -52,984
- Profit/Loss
- DKK -59,310
- Equity
- DKK -40,424
- Total Assets
- DKK 301,622
- Employees
- 0
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Endothel Pharma ApS has published its interim report for the period August 31, 2016 – December 31, 2017.
About Endothel Pharma ApS
Endothel Pharma ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Rikke Stine Friis Fléron. The company is owned by Bo Jesper Hansen, Pär Ingemar Johansson and Trial-Lab Holding AB. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -43,536 and a net result of DKK -87,006 compared with DKK -81,618 the year before. Equity in the 2025 report amounted to DKK -462,946.